To evaluate the diagnostic utility of serum ferritin in culture-confirmed neonatal sepsis and assess its incorporation into the existing septic screen, addressing current diagnostic challenges.
Key Findings:
Serum ferritin levels were significantly elevated in neonates with culture-confirmed sepsis compared to those without, with a p-value < 0.05.
Incorporating serum ferritin into the septic screen improved diagnostic sensitivity from X% to Y% and specificity from A% to B%.
The study highlighted the potential of serum ferritin as a reliable biomarker for neonatal sepsis, warranting further investigation.
Interpretation:
Serum ferritin may serve as a valuable adjunct in diagnosing neonatal sepsis, particularly in resource-limited settings where traditional methods have limitations, potentially improving patient outcomes.
Limitations:
The study was conducted in a single center, which may limit generalizability and introduce site-specific biases.
Sample size may not be large enough to draw definitive conclusions, necessitating further studies.
Potential confounding factors related to other inflammatory conditions were not fully controlled, which could affect results.
Conclusion:
Incorporating serum ferritin into the septic screen can enhance the diagnostic accuracy for neonatal sepsis, potentially reducing unnecessary antibiotic use and improving clinical outcomes.
